These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24926284)

  • 1. Behavioral and neurophysiological effects of transdermal rotigotine in atypical parkinsonism.
    Moretti DV; Binetti G; Zanetti O; Frisoni GB
    Front Neurol; 2014; 5():85. PubMed ID: 24926284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.
    Moretti DV; Binetti G; Zanetti O; Frisoni GB
    Neuropsychiatr Dis Treat; 2014; 10():1003-9. PubMed ID: 24940065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-ergot dopamine agonist rotigotine as a promising therapeutic tool in atypical parkinsonism syndromes: a 24 months pilot observational open-label study.
    Moretti DV; Binetti G; Zanetti O; Frisoni GB
    Neuropharmacology; 2014 Oct; 85():284-9. PubMed ID: 24915072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
    Kim JM; Chung SJ; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
    BMC Neurol; 2015 Feb; 15():17. PubMed ID: 25879416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical parkinsonian syndromes in a North African tertiary referral center.
    Nasri A; Ben Djebara M; Sghaier I; Mrabet S; Zidi S; Gargouri A; Kacem I; Gouider R
    Brain Behav; 2021 Jan; 11(1):e01924. PubMed ID: 33179436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study.
    Elmer LW; Surmann E; Boroojerdi B; Jankovic J
    Parkinsonism Relat Disord; 2012 Jun; 18(5):488-93. PubMed ID: 22326237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.
    Kaasinen V; Kankare T; Joutsa J; Vahlberg T
    J Nucl Med; 2019 Dec; 60(12):1757-1763. PubMed ID: 30979821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease.
    Giladi N; Boroojerdi B; Surmann E
    J Neural Transm (Vienna); 2013 Sep; 120(9):1321-9. PubMed ID: 23508526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotigotine transdermal system for the treatment of Parkinson's disease.
    Pham DQ; Nogid A
    Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
    Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
    Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal Patch of Rotigotine Attenuates Freezing of Gait in Patients with Parkinson's Disease: An Open-Label Comparative Study of Three Non-Ergot Dopamine Receptor Agonists.
    Ikeda K; Hirayama T; Takazawa T; Kawabe K; Iwasaki Y
    Intern Med; 2016; 55(19):2765-2769. PubMed ID: 27725534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
    Bocchetta M; Iglesias JE; Chelban V; Jabbari E; Lamb R; Russell LL; Greaves CV; Neason M; Cash DM; Thomas DL; Warren JD; Woodside J; Houlden H; Morris HR; Rohrer JD
    J Mov Disord; 2020 Jan; 13(1):39-46. PubMed ID: 31552724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of atypical parkinsonian syndromes.
    Lo RY
    Tzu Chi Med J; 2022; 34(2):169-181. PubMed ID: 35465274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmotor Features in Atypical Parkinsonism.
    Bhatia KP; Stamelou M
    Int Rev Neurobiol; 2017; 134():1285-1301. PubMed ID: 28805573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular predictors of survival among atypical parkinsonian syndromes in a North African tertiary referral center.
    Sghaier I; Nasri A; Atrous A; Abida Y; Gharbi A; Souissi A; Mrabet S; Ben Djebara M; Kacem I; Gargouri-Berrechid A; Gouider R
    J Neurol Sci; 2024 Sep; 464():123155. PubMed ID: 39106638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.
    Zhang ZX; Shang HF; Hu X; Chen S; Zhao Z; Du X; Surmann E; Bauer L; Asgharnejad M
    Parkinsonism Relat Disord; 2016 Jul; 28():49-55. PubMed ID: 27172830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.
    Oertel W; Trenkwalder C; Beneš H; Ferini-Strambi L; Högl B; Poewe W; Stiasny-Kolster K; Fichtner A; Schollmayer E; Kohnen R; García-Borreguero D;
    Lancet Neurol; 2011 Aug; 10(8):710-20. PubMed ID: 21705273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.